161 – 170 of 317
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The necessity of having FVIII in VWF concentrates
2010) 3rd Annual Congress of the European Association for Haemophilia and Allied Disorders In Haemophilia 16(2). p.400-400(
- Contribution to journal › Published meeting abstract
-
Mark
FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
(
- Contribution to journal › Article
-
Mark
A prospective, randomized, and crossover study of an activated prothrombin complex concentrate for secondary prophylaxis in patients with hemophilia A and inhibitors (Pro-FEIBA): subject demographics and safety data
2010) XXIXth International Congress of the World Federation of Hemophilia In Haemophilia 16(Suppl. 4). p.31-31(
- Contribution to journal › Published meeting abstract
-
Mark
Considerations in the laboratory assessment of haemostasis
(
- Contribution to journal › Scientific review
-
Mark
Devising a best practice approach to prophylaxis in boys with severe haemophilia: evaluation of current treatment strategies
(
- Contribution to journal › Scientific review
-
Mark
Why is the frequency of inhibitors increasing among Swedish children with severe hemophilia A?
(
- Contribution to journal › Published meeting abstract
-
Mark
Clinical issues in inhibitors
(
- Contribution to journal › Scientific review
-
Mark
Use and limitations of APTT as a screening test for mild bleeding disorders
(
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life in parents of children with haemophilia - results of the ESCHQoL study
(
- Contribution to journal › Published meeting abstract
-
Mark
Differential response to bypassing agents
(
- Contribution to journal › Published meeting abstract